Blum Robert I

Blum Robert I is listed in filings as President & CEO at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Mar 31, 2025 to May 28, 2026. Reported amounts are shown as $611.3K to $204.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.